Skeletal accumulation of fluorescently-tagged zoledronate is higher in animals with early stage chronic kidney disease

PURPOSE/INTRODUCTION: Chronic kidney disease (CKD) patients suffer from increased rates of skeletal related mortality from changes driven by biochemical abnormalities. Bisphosphonates are commonly used in reducing fracture risk in a variety of diseases yet, their use is not recommended in advanced s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Osteoporos Int
Asıl Yazarlar: Swallow, Elizabeth A., Aref, Mohammad W., Neal, Chen, Innocent, Byiringiro, Hammond, Max A., McCarthy, Brian P., Territo, Paul R., Kamocka, Malgorzata M., Seth, Winfree, Dunn, Kenneth W., Moe, Sharon M., Allen, Matthew R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6103914/
https://ncbi.nlm.nih.gov/pubmed/29947866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-018-4589-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller